Finesse Solutions

Activities: Analysis

Trending Articles

  1. Serialisation and data connectivity: Part I The new wrinkle in your supply chain
  2. Liquid versus lyophilised: overcoming the challenges of high-potency formulations in modern pharma Formulating highly potent (HiPo) compounds presents unique challenges that require expertise and precise decision making
  3. SGS’s Shanghai Health Science laboratory completes US FDA inspection with zero 483 observations SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an...
  4. Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche Acquisition extends Lonza’s US Biologics footprint with a significant presence on the West Coast, complementing its existing global manufacturing network
  5. SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Manufacturing

Finesse Solutions offers G3Lite SmartController for single-use bioreactors

Brings the benefits of industrial automation reliability and scalability in affordable package
Manufacturing

Alvotech and Finesse enter into biomanufacturing collaboration

First manufacturing suite expected to be in place by the end of 2015
Manufacturing

ATMI and Finesse Solutions sign distribution agreement

Will allow both companies to offer seamless support for single-use bioreactor systems
Manufacturing

Finesse Solutions moves to new facility in Santa Clara, US

New building includes an expanded Class 10,000 cleanroom for manufacturing single-use sensors
Manufacturing

ATMI and Finesse sign bioprocess reactor agreement

ATMI PadReactor system and Finesse controller technology to be offered as a turnkey system
Subscribe now